Cargando…

Editorial: Hepatocellular Carcinoma: From Basic Research to Clinical Trials

Detalles Bibliográficos
Autores principales:	He, Xing-Xing, Ye, Da-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198591/ https://www.ncbi.nlm.nih.gov/pubmed/35719944 http://dx.doi.org/10.3389/fonc.2022.905654

Ejemplares similares

Editorial: Meningioma: From Basic Research to Clinical Translational Study
por: Ho, Allen, et al.
Publicado: (2021)

Editorial: Peritoneal Metastasis of Gastric Cancer: From Basic Research to Clinical Application
por: Zhou, Heng, et al.
Publicado: (2022)

Editorial: Meningioma: From basic research to clinical translational study, volume II
por: Tang, Hailiang, et al.
Publicado: (2023)

Editorial: Multidrug Resistance in Cancer: Pharmacological Strategies from Basic Research to Clinical Issues
por: Riganti, Chiara, et al.
Publicado: (2015)

Editorial: Combinatorial Approaches for Cancer Treatment: From Basic to Translational Research
por: Cerrato, Aniello, et al.
Publicado: (2022)

Editorial: Immunotherapy in Hepatocellular Carcinoma
por: Li, Bin, et al.
Publicado: (2021)

Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma
por: Yang, Jin-Cui, et al.
Publicado: (2022)

Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma
por: Huang, Ziyue, et al.
Publicado: (2023)

Editorial: Biomarkers of Immune-Checkpoint-Inhibitor Immunotherapies in Hepatocellular Carcinomas
por: Guo, Zhanjun, et al.
Publicado: (2022)

Editorial: Noise-induced hearing loss: From basic to clinical research
por: Huang, Zhiwu, et al.
Publicado: (2023)

Ruptured Hepatocellular Carcinoma: Current Status of Research
por: Xia, Feng, et al.
Publicado: (2022)

Research Progress of DUB Enzyme in Hepatocellular Carcinoma
por: Zhao, Jie, et al.
Publicado: (2022)

Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC)
por: Zhao, Pin, et al.
Publicado: (2021)

Editorial: Bench to bedside: translating pre-clinical research into clinical trials for childhood brain tumors
por: Endersby, Raelene, et al.
Publicado: (2023)

Mechanisms of Neoantigen-Targeted Induction of Pyroptosis and Ferroptosis: From Basic Research to Clinical Applications
por: Yu, Jie, et al.
Publicado: (2021)

Lenvatinib as second-line treatment in patients with unresectable hepatocellular carcinoma: A retrospective analysis
por: Qin, He-nan, et al.
Publicado: (2022)

Progression of hepatocellular carcinoma after radiofrequency ablation: Current status of research
por: Wu, Shilun, et al.
Publicado: (2022)

Hepatocellular Carcinoma Differentiation: Research Progress in Mechanism and Treatment
por: Song, Jianning, et al.
Publicado: (2022)

Research progress of spontaneous ruptured hepatocellular carcinoma: Systematic review and meta-analysis
por: Wang, Chunling, et al.
Publicado: (2022)

The Role of Immune Checkpoint Blockade in the Hepatocellular Carcinoma: A Review of Clinical Trials
por: Ozer, Muhammet, et al.
Publicado: (2021)

MAPK-RAP1A Signaling Enriched in Hepatocellular Carcinoma Is Associated With Favorable Tumor-Infiltrating Immune Cells and Clinical Prognosis
por: Li, Hailin, et al.
Publicado: (2021)

Editorial: Radiotheranostics: From basic research to clinical application
por: Gareev, Kamil G., et al.
Publicado: (2023)

A New Clinical Nomogram From the TCGA Database to Predict the Prognosis of Hepatocellular Carcinoma
por: Ye, Dingde, et al.
Publicado: (2021)

Editorial: Clinical cancer research in vulnerable populations
por: Tack, Laura, et al.
Publicado: (2023)

High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma
por: Wang, Xuequan, et al.
Publicado: (2022)

Editorial: New understandings and research in anal squamous cell carcinoma
por: Kim, Stefano, et al.
Publicado: (2023)

Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma
por: You, Junqi, et al.
Publicado: (2023)

Hepatic arterial infusion chemotherapy in hepatocellular carcinoma: A bibliometric and knowledge-map analysis
por: Li, Mei, et al.
Publicado: (2023)

The Basic Research of the Combinatorial Therapy of ABT-199 and Homoharringtonine on Acute Myeloid Leukemia
por: Shi, Yuanfei, et al.
Publicado: (2021)

Corrigendum: High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma
por: Wang, Xuequan, et al.
Publicado: (2023)

Prognostic and immunological role of sulfatide-related lncRNAs in hepatocellular carcinoma
por: Huang, Xing Feng, et al.
Publicado: (2023)

Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma
por: Xie, Shuqi, et al.
Publicado: (2023)

The Mechanism and Clinical Significance of Circular RNAs in Hepatocellular Carcinoma
por: Huang, Ziyue, et al.
Publicado: (2021)

Editorial: Prognostic Research and Precision Oncology in Upper Tract Urothelial Carcinoma
por: Sheu, Zai-Lin, et al.
Publicado: (2022)

Associations of DDX60L With the Clinical Features and Prognosis of Hepatocellular Carcinoma
por: Ye, Ziqi, et al.
Publicado: (2022)

Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS
por: Hu, Yi-Xin, et al.
Publicado: (2021)

Sintilimab plus Lenvatinib conversion therapy for intermediate/locally advanced hepatocellular carcinoma: A phase 2 study
por: Wang, Lijun, et al.
Publicado: (2023)

Traditional Herbal Medicine: A Review of Potential of Inhibitory Hepatocellular Carcinoma in Basic Research and Clinical Trial
por: Wang, Zhidong, et al.
Publicado: (2013)

Metabolism-related signatures is correlated with poor prognosis and immune infiltration in hepatocellular carcinoma via multi-omics analysis and basic experiments
por: Shen, Jiapei, et al.
Publicado: (2023)

Editorial: Brain stimulation: From basic research to clinical use
por: Benali, Alia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ckvdj23riu3joqnkiofeias2sn